{"&cites=5181895643400921433&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy":[{"title":"Nivolumab plus ipilimumab versus sunitinib in advanced renal-cell carcinoma","url":"https://www.nejm.org/doi/full/10.1056/nejmoa1712126","authors":["RJ Motzer","RJ Motzer NM Tannir","RJ Motzer NM Tannir DF McDermott…"],"year":2018,"numCitations":1247,"pdf":"https://www.nejm.org/doi/full/10.1056/nejmoa1712126","citationUrl":"http://scholar.google.com/scholar?cites=13898631485117911629&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:TVKDlrLb4cAJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=13898631485117911629&hl=en&as_sdt=2005&sciodt=0,5&scioq=systemic+therapy","publication":"Mass Medical Soc","p":1,"exp":1596876833728},{"title":"Systemic therapy for metastatic renal-cell carcinoma","url":"https://www.nejm.org/doi/full/10.1056/NEJMra1601333","authors":["TK Choueiri","TK Choueiri RJ Motzer"],"year":2017,"numCitations":424,"pdf":"https://medicinainternaelsalvador.com/wp-content/uploads/2017/02/Systemic-Therapy-for-Metastatic-Renal-Cell.pdf","citationUrl":"http://scholar.google.com/scholar?cites=16656632348319106054&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:BkTXw94-KOcJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=16656632348319106054&hl=en&as_sdt=2005&sciodt=0,5&scioq=systemic+therapy","publication":"Mass Medical Soc"},{"title":"Sunitinib alone or after nephrectomy in metastatic renal-cell carcinoma","url":"https://www.nejm.org/doi/full/10.1056/NEJMoa1803675","authors":["A Méjean","A Méjean A Ravaud","A Méjean A Ravaud S Thezenas…"],"year":2018,"numCitations":332,"pdf":"https://www.nejm.org/doi/full/10.1056/NEJMoa1803675","citationUrl":"http://scholar.google.com/scholar?cites=2759106540828352675&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:o-CHz8dQSiYJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=2759106540828352675&hl=en&as_sdt=2005&sciodt=0,5&scioq=systemic+therapy","publication":"Mass Medical Soc"},{"title":"Treatment of renal cell carcinoma: current status and future directions","url":"https://acsjournals.onlinelibrary.wiley.com/doi/abs/10.3322/caac.21411","authors":["PC Barata","PC Barata BI Rini"],"year":2017,"numCitations":165,"pdf":"https://acsjournals.onlinelibrary.wiley.com/doi/pdf/10.3322/caac.21411","citationUrl":"http://scholar.google.com/scholar?cites=7801829241769079319&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:F7LmCVyqRWwJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=7801829241769079319&hl=en&as_sdt=2005&sciodt=0,5&scioq=systemic+therapy","publication":"Wiley Online Library"},{"title":"Updated European Association of Urology Guidelines: recommendations for the treatment of first-line metastatic clear cell renal cancer","url":"https://www.sciencedirect.com/science/article/pii/S0302283817310011","authors":["T Powles","T Powles L Albiges","T Powles L Albiges M Staehler","T Powles L Albiges M Staehler K Bensalah…"],"year":2018,"numCitations":134,"pdf":"http://medi-guide.meditool.cn/ymtpdf/FD622916-D07B-077E-7F95-949D262ADFB7.pdf","citationUrl":"http://scholar.google.com/scholar?cites=15384777887830983052&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:jEFzGPq1gdUJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15384777887830983052&hl=en&as_sdt=2005&sciodt=0,5&scioq=systemic+therapy","publication":"Elsevier"},{"title":"Cabozantinib versus sunitinib as initial therapy for metastatic renal cell carcinoma of intermediate or poor risk (Alliance A031203 CABOSUN randomised trial) …","url":"https://www.sciencedirect.com/science/article/pii/S0959804918301813","authors":["TK Choueiri","TK Choueiri C Hessel","TK Choueiri C Hessel S Halabi","TK Choueiri C Hessel S Halabi B Sanford…"],"year":2018,"numCitations":121,"pdf":"https://www.sciencedirect.com/science/article/pii/S0959804918301813","citationUrl":"http://scholar.google.com/scholar?cites=14929455411752643417&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:WauM65gUMM8J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=14929455411752643417&hl=en&as_sdt=2005&sciodt=0,5&scioq=systemic+therapy","publication":"Elsevier"},{"title":"Patient-reported outcomes of patients with advanced renal cell carcinoma treated with nivolumab plus ipilimumab versus sunitinib (CheckMate 214): a randomised …","url":"https://www.sciencedirect.com/science/article/pii/S1470204518307782","authors":["D Cella","D Cella V Grünwald","D Cella V Grünwald B Escudier","D Cella V Grünwald B Escudier HJ Hammers…"],"year":2019,"numCitations":77,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/pmc6701190/","citationUrl":"http://scholar.google.com/scholar?cites=7861525857313602070&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:Frq5dR3AGW0J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=7861525857313602070&hl=en&as_sdt=2005&sciodt=0,5&scioq=systemic+therapy","publication":"Elsevier"},{"title":"Targeted therapies for renal cell carcinoma","url":"https://www.nature.com/articles/nrneph.2017.82.pdf?origin=ppub","authors":["EM Posadas","EM Posadas S Limvorasak","EM Posadas S Limvorasak RA Figlin"],"year":2017,"numCitations":74,"citationUrl":"http://scholar.google.com/scholar?cites=15956232143194829285&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:5THMMJjsb90J:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=15956232143194829285&hl=en&as_sdt=2005&sciodt=0,5&scioq=systemic+therapy","publication":"nature.com"},{"title":"Current and emerging therapies for first-line treatment of metastatic clear cell renal cell carcinoma","url":"https://www.sciencedirect.com/science/article/pii/S0305737218301282","authors":["MB Atkins","MB Atkins NM Tannir"],"year":2018,"numCitations":64,"pdf":"https://www.sciencedirect.com/science/article/pii/S0305737218301282","citationUrl":"http://scholar.google.com/scholar?cites=282719972809875182&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:7p49PlFs7AMJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=282719972809875182&hl=en&as_sdt=2005&sciodt=0,5&scioq=systemic+therapy","publication":"Elsevier"},{"title":"Cabozantinib, a new standard of care for patients with advanced renal cell carcinoma and bone metastases? Subgroup analysis of the METEOR trial","url":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804840/","authors":["B Escudier","B Escudier T Powles","B Escudier T Powles RJ Motzer","B Escudier T Powles RJ Motzer T Olencki…"],"year":2018,"numCitations":55,"pdf":"https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6804840/","citationUrl":"http://scholar.google.com/scholar?cites=7688448170801901123&as_sdt=2005&sciodt=0,5&hl=en&scioq=systemic+therapy","relatedUrl":"http://scholar.google.com/scholar?q=related:Qy6mTuDasmoJ:scholar.google.com/&scioq=&hl=en&as_sdt=2005&sciodt=0,5","urlVersionsList":"http://scholar.google.com/scholar?cluster=7688448170801901123&hl=en&as_sdt=2005&sciodt=0,5&scioq=systemic+therapy","publication":"ncbi.nlm.nih.gov"}]}